Internet | Biotech Stock Review | News On Internet and Biotech Stocks. | Page 3

2023 Watch List

Adding Dario Health (DRIO) $2.81 to Watch List.

Editor / Curator - August 25, 2023

2023 Watch List

With Help of Sanofi (SNY), Dario Health (DRIO) Builds Scientific Case...

Editor / Curator - August 24, 2023

All News

Pressure BioSciences, (PBIO) $0.28 Provides Business Update, and Offers Guidance for...

Editor / Curator - August 22, 2023

Biotech News

Mission to Sell the World’s Last Cigarette Before the 22nd Century

Editor / Curator - August 20, 2023

2023 Watch List

COMPASS Pathways (CMPS) Announces Up to $285 Million Private Placement

Editor / Curator - August 16, 2023

All News

Our 10 Top Turnaround Situations Under $5.00.

Editor / Curator - August 9, 2023

Biotech News

Tsunami of Business Headed Pressure Bio’s (PBIO) Way?

Editor / Curator - July 10, 2023

2023 Watch List

Report: Is Psycheceutical BioScience (BWVI) One of the Most Important Companies...

Editor / Curator - June 27, 2023

All News

Is Ultra-Shear’s™ Nano-THC the Most Powerful and Fast-Acting THC in the...

Editor / Curator - June 27, 2023

Psychedelic Stock Review

Billionaire, Point 72’s Steve Cohen, Continues to Support Psychedelic Research.

Editor / Curator - June 19, 2023

1 234...80 Page 3 of 80

Latest article

Two Reports and a Profile on Sekur Private Private Data (SWISF).

Cybersecurity Editor / Curator - September 25, 2023

RELATED: Sekur Private Data Ltd.'s SekurVPN Swiss Hosted, Privacy VPN Records Sales up over 100% Month-Over-Month

NobleCon 19 Investor Conference | Boca Raton FL | December 3-5

Investor Conference Editor / Curator - September 25, 2023

Noble Collaborates with Florida Atlantic University to host NobleCon19 Who should attend? Public companies from any business sector with...

SekurMessenger vs. the WhatsApp Messenger.

Cybersecurity Editor / Curator - September 24, 2023

Can the World’s Most Secure Text Messenger and Email Provider Challenge the Industry Leader WhatsApp? Can A Tiny...

The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062